Home › Funds › Syverson Strege & Co › ABBV

Syverson Strege & Co position in ABBV

ABBVIE INC · Health Care

Syverson Strege & Co reported holding 6,245 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.37% of its reported portfolio and ranking #31 among its reported holdings. Syverson Strege & Co has disclosed ABBV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)6.25K sh
Reported value held$1.63M
Portfolio Weight0.37%
First reportedQ2 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Syverson Strege & Co's ABBV position evolved

Syverson Strege & Co first disclosed a stake in ABBV in Q2 2024 at 4,056 shares (US$696K). The position peaked in Q3 2026 at 6,245 shares, worth US$1.6M. Across 10 filings, Syverson Strege & Co increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,245 shares valued at US$1.6M — an increase of 375 shares quarter over quarter.. Notable position changes include a 40% increase in Q4 2024 (shares rose 19% over the following quarter), a 31% increase in Q2 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 4.06K $695.68K New
Q3 2024 3.25K $641.81K Reduce
Q4 2024 4.55K $809.25K Add
Q1 2025 4.59K $962.12K Add
Q2 2025 6.01K $1.11M Add
Q3 2025 6.50K $1.50M Add
Q4 2025 6.57K $1.50M Add
Q1 2026 6.49K $1.41M Reduce
Q2 2026 5.87K $1.48M Reduce
Q3 2026 6.25K $1.63M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Syverson Strege & Co held ABBV?

Syverson Strege & Co has disclosed ABBV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Syverson Strege & Co's current position in ABBV?

As of Q3 2026, Syverson Strege & Co holds 6.25K shares of ABBV (ABBVIE INC), valued at $1.63M, representing 0.37% of its reported portfolio and ranking #31.

Has Syverson Strege & Co been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Syverson Strege & Co increased its position in ABBV. The position peaked in Q3 2026 at 6.25K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.